Norges Bank’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Norges Bank’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,109	Closed	-$508K	–	2197
2016 Q4	$508K	Hold	5,109	–	–	﹤0.01%	2112
2016 Q3	$546K	Sell	5,109 -2,750	-35%	-$330K	﹤0.01%	2108
2016 Q2	$807K	Hold	7,859	–	–	﹤0.01%	2092
2016 Q1	$722K	Hold	7,859	–	–	﹤0.01%	2106
2015 Q4	$1.13M	Buy	7,859 +7,234	+1,157%	+$941K	﹤0.01%	2098
2015 Q3	$65K	Hold	625	–	–	﹤0.01%	2260
2015 Q2	$102K	Buy	+625	New	+$106K	﹤0.01%	2252

Other funds holding SIOX

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return

Norges Bank's SIOX Position: Q1 2017 in Review

Norges Bank sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2017, closing a stake of 5,109 shares — an estimated $508K sold.

Norges Bank first reported a position in SIOX in Q2 2015 and held it in 7 quarters. The position peaked at $1.13M in Q4 2015. 97 funds tracked by Wall St. Rank hold SIOX as of Q1 2017.

Norges Bank reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Norges Bank sold 5,109 Sio Gene Therapies Inc. Common Stock shares in Q1 2017, an estimated $508K.
Norges Bank first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 7 quarters.
Norges Bank's Sio Gene Therapies Inc. Common Stock position peaked at $1.13M in Q4 2015.
97 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2017.

Based on Norges Bank's 13F filing for Q1 2017, filed 10 May 2017.